Delivery Order SPE2DB20D2104-SPE2DB25FMQRB
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $1,503.07 and an ultimate completion date of August 13, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its Corporate Office division, has...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,778.38 and a period of performance through April 24, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting, at a ceiling value of $8,453.38. This is a delivery order contract with a firm fixed-price pricing type. The period of performance extends until August 26, 2024. The contract is not set aside for any specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 8 mg Ondansetron hydrochloride tablets, used to treat nausea and vomiting, with a ceiling value of $5,665.56 and a completion date of January 20, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,958,111 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a Firm Fixed Price pricing type and a total ceiling value of $17,185.18. It is not set aside for any specific type of business. The contract has an ultimate...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products. The contract has a ceiling value of $7,719.26 and a performance period through May 27, 2025. It is a firm-fixed-price contract for the delivery of ondansetron orally disintegrating tablets, a medication used to treat nausea and vomiting. The contract is not set-aside and was awarded through open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,872.79 firm fixed-price contract is for the supply of Ondansetron HCL 4 mg tablets, which are used to treat nausea and vomiting. The contract has a performance period through July 16, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The Delivery Order has a ceiling value of $1,534.83 and a period of performance through October 11, 2023. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,962.53. The contract is for the supply of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,828,704 units of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $19,733.40 and a completion date of April 8, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen...